Gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2

Journal of Neurochemistry

Volumn 120, Issue 2, 2012, Pages 239-247

  Shi, Xiao ^a   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ciliary neurotrophic factor; leukemia inhibitory factor; noradrenergic; sympathetic neurons

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CILIARY NEUROTROPHIC FACTOR RECEPTOR; GLYCOPROTEIN GP 130; JANUS KINASE; LACTACYSTIN; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; STAT3 PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE CELL; UBIQUITINATION;

ANIMALS; ANIMALS, NEWBORN; BUTADIENES; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR GP130; DOPAMINE BETA-HYDROXYLASE; ENZYME INHIBITORS; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HALF-LIFE; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA INHIBITORY FACTOR; LEUPEPTINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; NITRILES; PREGNANCY; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TYROSINE 3-MONOOXYGENASE; UBIQUITINATION;

EID: 84055201353     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07539.x     Document Type: Article

References (40)

1. Aoyama T., Takimoto Y., Pennica D., Inoue R., Shinoda E., Hattori R., Yui Y., and, Sasayama S., (2000) Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J. Mol. Cell. Cardiol. 32, 1821-1830.
2. Chuang D., Zsilla G., and, Costa E., (1975) Turnover rate of tyrosine hydroxylase during Trans-synaptic induction. Mol. Pharmacol. 11, 784-794.
3. Ciechanover A., (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 6, 79-87.
4. Ciesielska A., Joniec I., Kurkowska-Jastrzebska I., Przybylkowski A., Gromadzka G., Czlonkowska A., and, Czlonkowski A., (2007) Influence of age and gender on cytokine expression in a murine model of Parkinson's disease. Neuroimmunomodulation 14, 255-265. (Pubitemid 351339992)
5. Doskeland A. P., and, Flatmark T., (2002) Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur. J. Biochem. 269, 1561-1569. (Pubitemid 34227098)
6. Dziennis S., and, Habecker B. A., (2003) Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways. J. Biol. Chem. 278, 15897-15904. (Pubitemid 36799705)
7. Elmarakby A. A., and, Imig J. D., (2010) Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin. Sci. (Lond) 118, 291-301.
8. Fann M. J., and, Patterson P. H., (1993) A novel approach to screen for cytokine effects on neuronal gene expression. J. Neurochem. 61, 1349-1355. (Pubitemid 23285093)
9. Fernandez E., and, Craviso G. L., (1999) Protein synthesis blockade differentially affects the degradation of constitutive and nicotinic receptor-induced tyrosine hydroxylase protein level in isolated bovine chromaffin cells. J. Neurochem. 73, 169-178. (Pubitemid 29289124)
10. Fischer P., and, Hilfiker-Kleiner D., (2008) Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br. J. Pharmacol. 153 (Suppl. 1), S414-S427. (Pubitemid 351341017)
11. Frangogiannis N. G., Smith C. W., and, Entman M. L., (2002) The inflammatory response in myocardial infarction. Cardiovasc. Res. 53, 31-47. (Pubitemid 34020764)
12. Franklin J. L., and, Johnson E. M., (1998) Control of neuronal size homeostasis by trophic factor-mediated coupling of protein degradation to protein synthesis. J. Cell Biol. 142, 1313-1324. (Pubitemid 28429112)
13. Grassi G., Seravalle G., and, Dell'oro R., (2010) Sympathetic activation in obesity: a noninnocent bystander. Hypertension 56, 338-340.
14. Gwechenberger M., Mendoza L. H., Youker K. A., Frangogiannis N. G., Smith C. W., Michael L. H., and, Entman M. L., (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546-551. (Pubitemid 29061871)
15. Hotamisligil G. S., (2006) Inflammation and metabolic disorders. Nature 444, 860-867. (Pubitemid 46024993)
16. Jho D. H., Engelhard H. H., Gandhi R., Chao J., Babcock T., Ong E., and, Espat N. J., (2004) Ciliary neurotrophic factor upregulates ubiquitin-proteasome components in a rat model of neuronal injury. Cytokine 27, 142-151. (Pubitemid 39078520)
17. Kreusser M. M., Buss S. J., Krebs J., Kinscherf R., Metz J., Katus H. A., Haass M., and, Backs J., (2008) Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart. J. Mol. Cell. Cardiol. 44, 380-387. (Pubitemid 351226196)
18. Li W., Knowlton D., Woodward W. R., and, Habecker B. A., (2003) Regulation of noradrenergic function by inflammatory cytokines and depolarization. J. Neurochem. 86, 774-783. (Pubitemid 36897456)
19. Li W., Knowlton D., Van Winkle D. M., and, Habecker B. A., (2004) Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am. J. Physiol. Heart Circ. Physiol. 286, H2229-H2236. (Pubitemid 38685237)
20. Lopez Verrilli M. A., Pirola C. J., Pascual M. M., Dominici F. P., Turyn D., and, Gironacci M. M., (2009) Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J. Neurochem. 109, 326-335.
21. McNaught K. S., Jackson T., JnoBaptiste R., Kapustin A., and, Olanow C. W., (2006) Proteasomal dysfunction in sporadic Parkinson's disease. Neurology 66, S37-S49.
22. Morgan D. A., and, Rahmouni K., (2010) Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J. Hypertens. 28, 1913-1919.
23. Mueller R. A., Thoenen H., and, Axelrod J., (1969) Inhibition of trans-synaptically increased tyrosine hydroxylase activity by cycloheximide and actinomycin D. Mol. Pharmacol. 5, 463-469.
24. Nakashima A., Mori K., Kaneko Y. S., Hayashi N., Nagatsu T., and, Ota A., (2011) Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme. Biochem. Biophys. Res. Commun. 407, 343-347.
25. Nawa H., Nakanishi S., and, Patterson P. H., (1991) Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J. Neurochem. 56, 2147-2150.
26. Niu H., Ye B. H., and, la-Favera R., (1998) Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12, 1953-1961. (Pubitemid 28323870)
27. Oshikawa T., Kuroiwa H., Yano R., Yokoyama H., Kadoguchi N., Kato H., and, Araki T., (2009) Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice. Cell. Mol. Neurobiol. 29, 769-777.
28. Ozawa Y., Nakao K., Kurihara T., Shimazaki T., Shimmura S., Ishida S., Yoshimura A., Tsubota K., and, Okano H., (2008) Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation. J. Biol. Chem. 283, 24561-24570.
29. Parrish D. C., Gritman K., Van Winkle D. M., Woodward W. R., Bader M., and, Habecker B. A., (2008) Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am. J. Physiol. Heart Circ. Physiol. 294, H99-H106.
30. Parrish D. C., Alston E. N., Rohrer H., Nkadi P., Woodward W. R., Schutz G., and, Habecker B. A., (2010) Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves. Exp. Physiol. 95, 304-314.
31. Patterson P. H., and, Chun L. L., (1977) The induction of acetylcholine synthesis in primary cultures of dissociated rat sympathetic neurons. I. Effects of conditioned medium. Dev. Biol. 56, 263-280. (Pubitemid 8064195)
32. Pellegrino M. J., Parrish D. C., Zigmond R. E., and, Habecker B. A., (2011) Cytokines inhibit norepinephrine transporter expression by decreasing Hand2. Mol. Cell. Neurosci. 46, 671-680.
33. Rao M. S., Sun Y., Escary J. L., Perreau J., Tresser S., Patterson P. H., Zigmond R. E., Brulet P., and, Landis S. C., (1993) Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11, 1175-1185.
34. Rubart M., and, Zipes D. P., (2005) Mechanisms of sudden cardiac death. J. Clin. Invest. 115, 2305-2315. (Pubitemid 41266189)
35. Saadat S., Sendtner M., and, Rohrer H., (1989) Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J. Cell Biol. 108, 1807-1816. (Pubitemid 19130513)
36. Stanke M., Duong C. V., Pape M., et al. (2006) Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 133, 141-150. (Pubitemid 43169328)
37. Tank A. W., Ham L., and, Curella P., (1986) Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase. Mol. Pharmacol. 30, 486-496. (Pubitemid 17202428)
38. Wu D. K., and, Cepko C. L., (1994) The stability of endogenous tyrosine hydroxylase protein in PC-12 cells differs from that expressed in mouse fibroblasts by gene transfer. J. Neurochem. 62, 863-872. (Pubitemid 24064495)
39. Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M. J., and, Patterson P. H., (1989) The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246, 1412-1416. (Pubitemid 20018313)
40. Zigmond R. E., Hyatt-Sachs H., Mohney R. P., Schreiber R. C., Shadiack A. M., Sun Y., and, Vaccariello S. A., (1996) Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspect. Dev. Neurobiol. 4, 75-90. (Pubitemid 28144347)